Fred Hutchs Immunotherapy Integrated Research Center (IIRC) invites students who are nearing completion of their PhD, MD, or MD/PhDgraduate studies to apply for a 3-day, all-expenses paid symposium in Seattle. The program is designed for students interested in pursuing a postdoctoral trainingin immuno-oncology and will take place October 3-4, 2019 at Fred Hutchs Robert W. Day Campus. Activities around Seattle are planned for October 5, 2019. Students either currently studying topics in immuno-oncology or those who are interested in switching fields are equally encouraged to apply.
Immuno-oncology research at Fred Hutch builds on decades of pioneering work in basic immunology and transplantation with the overarching goal of discovering curative therapies for all cancers. Built from a solid foundation of translational research in solid and hematologic malignancies, our group includes strong research programs in cell therapy (TCR/CAR) and transplant immunotherapy, and is expanding in tumor microenvironment, immune checkpoint & regulation, immunogenomics, and therapeutic vaccines, among others.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.